多组学视角解析活络效灵丹治疗膝骨关节炎的关键活性成分与机制
该研究通过UHPLC-Q-Orbitrap-MS和HPLC鉴定活络效灵丹中53种化合物,以丹酚酸B为关键质量标志物,并在ACLT诱导的KOA小鼠模型中评价其疗效。多组学与网络药理学分析提示,SHIP1、PTPRC、细胞色素P450酶家族及JAK2/STAT3通路参与其改善KOA的作用。
要点
- 活络效灵丹可减轻ACLT诱导KOA小鼠疼痛、保护软骨细胞、减少氧化应激并改善骨参数。
- 丹酚酸B为活络效灵丹中含量最丰富的化合物,可能是治疗KOA的关键单体。
- SHIP1/PI3K/AKT与JAK2/STAT3通路及花生四烯酸代谢、免疫调节可能介导其作用。
核心结论
- 活络效灵丹是改善膝骨关节炎发展的有效药物,丹酚酸B可能是其治疗KOA的关键单体化合物。
研究设计与样本
- 研究采用UHPLC-Q-Orbitrap-MS和HPLC分析活络效灵丹化学成分,并以化学计量学进行质量控制。
- 采用前交叉韧带切断(ACLT)诱导的KOA小鼠模型评价活络效灵丹疗效,并结合蛋白质组学、脂质代谢组学、网络药理学和分子对接探索关键活性成分与机制。
主要发现
- 在活络效灵丹中鉴定出53种化合物,丹酚酸B为关键质量标志物和潜在抗KOA活性化合物。
- 活络效灵丹可减轻疼痛、保护软骨细胞、减少氧化应激并改善骨参数。
- 多组学联合分析提示SHIP1、PTPRC、细胞色素P450酶家族(包括Cyp1a2、Cyp2c29、Cyp2c50、Cyp2c544)及JAK2/STAT3通路在改善KOA中起重要作用。
- 可视化分析结果进一步提示活络效灵丹治疗KOA与SHIP1/PI3K/AKT和JAK2/STAT3通路、花生四烯酸代谢及免疫调节相关。
临床怎么用
- 活络效灵丹作为国家中医药管理局《古代经典名方目录》收录方剂,具有活血祛瘀、通络止痛功效,可用于气血瘀滞证候。
- 本研究发现丹酚酸B可作为活络效灵丹质量控制的关键指标成分,并可能为其治疗KOA的潜在活性单体。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Knee osteoarthritis (KOA) is a prevalent chronic knee joint disease, occurring mainly in the elderly and obese populations. In traditional Chinese medicine (TCM) theory, KOA is categorized as "knee bi" and "bi syndrome," primarily caused by external factors such as wind, cold, and dampness, as well as internal deficiencies. The treatment with Chinese herbal medicine focuses on dispelling wind, cold, and dampness, as well as promoting blood circulation and removing blood stasis. Huoluo Xiaoling Pellet (HXP), derived from Zhang Xichun's "The Records of Traditional Chinese and Western Medicine in Combination " during the Qing Dynasty, was known for its effects of activating blood circulation to remove stasis and alleviating pain by unblocking the collaterals, mainly used for treating conditions with stagnation of qi and blood. It has been included in the "Ancient Classic Prescriptions" by the National Administration of Traditional Chinese Medicine. However, the pharmacodynamic compounds, specific actions, and mechanisms of HXP on KOA have not yet been elucidated. AIM OF STUDY: Through qualitative and quantitative analysis, combined with multi-omics technology and network pharmacology, the key bioactive compounds and related mechanisms of HXP in improving knee osteoarthritis were explored. METHODS: UHPLC-Q-Orbitrap-MS and HPLC were used to analyze the chemical composition of HXP, chemometric analyses was used for quality control. The therapeutic effect of HXP was evaluated by Anterior Cruciate Ligament Transaction (ACLT)-induced KOA mouse model, and proteomics and lipid metabolomics were combined with network pharmacology and molecular docking techniques to explore for the key bioactive compounds and mechanisms. RESULTS: Identified 53 compounds in HXP, with Salvianolic acid B as a key quality marker and potential active compound for KOA. HXP reduced pain, protected chondrocytes, reduced oxidative stress, and improved bone parameters. The combined multi-omics analysis indicates that the protein targets of SHIP1, PTPRC, the cytochrome P450 enzyme family including Cyp1a2, Cyp2c29, Cyp2c50, Cyp2c544, as well as the JAK2/STAT3 pathway, play crucial roles in the improvement of KOA. CONCLUSION: Our results demonstrated that HXP was an effective drug to improve the development of KOA. Among them, Salvianolic acid B, the most abundant compound in HXP and the best computer simulation result, may be the key monomer compound of HXP for KOA treatment. The results of the visualisation analysis further contributed to our understanding of HXP treatment of KOA in terms of changes in SHIP1, PTPRC proteins and cytochrome P450 enzyme family. This is associated with the SHIP1/PI3K/AKT and JAK2/STAT3 pathways, as well as arachidonic acid metabolism and immune regulation.
引用
- Zhang J, Liu L, Lao Z, et al. Multi-omics perspective on Huoluo Xiaoling Pellet: key bioactive compounds and related mechanisms for the treatment of knee osteoarthritis. J Ethnopharmacol. 2025. PMID: 40210178. doi:10.1016/j.jep.2025.119761
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。